نتایج جستجو برای: repaglinide

تعداد نتایج: 366  

Journal: :The Biochemical journal 2003
Miki Okada Daisuke Takezawa Shuji Tachibanaki Satoru Kawamura Hiroshi Tokumitsu Ryoji Kobayashi

The NCS (neuronal calcium sensor) proteins, including neurocalcins, recoverins and visinin-like proteins are members of a family of Ca2+-sensitive regulators, each with three Ca2+-binding EF-hand motifs. In plants, lily CCaMK [chimaeric Ca2+/CaM (calmodulin)-dependent protein kinase] and its PpCaMK ( Physcomitrella patens CCaMK) homologue are characterized by a visinin-like domain with three EF...

Journal: :Circulation 2004
Katherine Esposito Dario Giugliano Francesco Nappo Raffaele Marfella

BACKGROUND Postprandial hyperglycemia may be a risk factor for cardiovascular disease. We compared the effects of two insulin secretagogues, repaglinide and glyburide, known to have different efficacy on postprandial hyperglycemia, on carotid intima-media thickness (CIMT) and markers of systemic vascular inflammation in type 2 diabetic patients. METHODS AND RESULTS We performed a randomized, ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2009
Janne T Backman Johanna Honkalammi Mikko Neuvonen Kaisa J Kurkinen Aleksi Tornio Mikko Niemi Pertti J Neuvonen

Gemfibrozil 1-O-beta-glucuronide is a mechanism-based inhibitor of cytochrome P450 2C8. We studied the recovery of CYP2C8 activity after discontinuation of gemfibrozil treatment using repaglinide as a probe drug, to estimate the in vivo turnover half-life of CYP2C8. In a randomized five-phase crossover study, nine healthy volunteers ingested 0.25 mg of repaglinide alone or after different time ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2011
Johanna Honkalammi Mikko Niemi Pertti J Neuvonen Janne T Backman

Gemfibrozil 1-O-β-glucuronide inactivates CYP2C8 irreversibly. We investigated the effect of gemfibrozil dose on CYP2C8 activity in humans using repaglinide as a probe drug. In a randomized, five-phase crossover study, 10 healthy volunteers ingested 0.25 mg of repaglinide 1 h after different doses of gemfibrozil or placebo. Concentrations of plasma repaglinide, gemfibrozil, their metabolites, a...

2012
Seema M. Dhole Pramod B. Khedekar Nikhil D. Amnerkar

BACKGROUND Repaglinide is a miglitinide class of antidiabetic drug used for the treatment of type 2 diabetes mellitus. A fast and reliable method for the determination of repaglinide was highly desirable to support formulation screening and quality control. OBJECTIVE UV spectrophotometric and reversed-phase high performance liquid chromatography (RP-HPLC) methods were developed for determinat...

2011
N. Kaushal S. Naz AK. Tiwary

BACKGROUND AND PURPOSE OF THE STUDY Herbal enhancers compared to the synthetic ones have shown less toxis effects. Coumarins have been shown at concentrations inhibiting phospoliphase C-Y (Phc-Y) are able to enhance tight junction (TJ) permeability due to hyperpoalation of Zonolous Occludense-1 (ZO-1) proteins. The purpose of this study was to evaluate the influence of ethanolic extract of Ange...

Journal: :Bioscience trends 2010
Boushra M El-Houssieny Lobna F Wahman Nadia M S Arafa

This study is an extension of the previous enhancement of dissolution properties of repaglinide using liquisolid compacts. The development and validation of a highperformance liquid chromatography (HPLC) assay for the determination of repaglinide concentration in rabbit plasma for pharmacokinetic studies is described. Repaglinide optimizing formula was orally administered to rabbits and blood s...

Journal: :Diabetes care 2002
Lawrence S Cozma Stephen D Luzio Gareth J Dunseath Kirsten W Langendorg Thomas Pieber David R Owens

OBJECTIVE To compare the effects of repaglinide, glipizide, and glibenclamide on insulin secretion and postprandial glucose after a single standard 500-kcal test meal. RESEARCH DESIGN AND METHODS A total of 12 type 2 diabetic patients with early diabetes (mean HbA(1c) of 6.1%) and 12 matched control subjects were enrolled in this randomized, double-blind, crossover trial. Subjects received pl...

2015
Miao Chen Cheng Hu Rong Zhang Feng Jiang Jie Wang Danfeng Peng Shanshan Tang Xue Sun Jing Yan Shiyun Wang Tao Wang Yuqian Bao Weiping Jia

The PSMD6 variant rs831571 has been identified as a susceptibility locus for type 2 diabetes mellitus (T2DM). This study aimed to investigate the association of this variant with therapeutic effects of oral antidiabetic drugs in Chinese T2DM patients. 209 newly diagnosed T2DM patients were randomly assigned to treatment with repaglinide or rosiglitazone for 48 weeks, and the therapeutic effects...

2009
Søren S Lund Lise Tarnow Merete Frandsen Bente B Nielsen Birgitte V Hansen Oluf Pedersen Hans-Henrik Parving Allan A Vaag

OBJECTIVES To study the effect of insulin treatment in combination with metformin or an insulin secretagogue, repaglinide, on glycaemic regulation in non-obese patients with type 2 diabetes. DESIGN Randomised, double blind, double dummy, parallel trial. SETTING Secondary care in Denmark between 2003 and 2006. PARTICIPANTS Non-obese patients (BMI </=27) with preserved beta cell function. ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید